people

Eightco Holdings Inc. Announces Nasdaq Ticker Symbol Change to ORBS, Advancing the AI Revolution

Dan Ives, renowned technology and AI expert and Wall Street analyst, to serve as Chairman of the Board In an…

1 month ago

Three global institutions win million dollar prize for the 2025 Antnio Champalimaud Vision Award

Valued at €1 million, it is the world's largest award in the field of vision, recognising work that combines scientific excellence,…

1 month ago

Startek Philippines earns Great Place to Work Certification for the third consecutive year

MUMBAI, India, Sept. 9, 2025 /PRNewswire/ -- Startek®, a digital-first global customer experience (CX) solutions provider, today announced that Startek…

1 month ago

GSMA calls for renewed focus on closing the Usage Gap as more than 3 billion people remain offline despite available mobile internet services

LONDON, Sept. 9, 2025 /PRNewswire/ -- 4.7 billion people, or 58% of the world's population, now use mobile internet services…

1 month ago

Four initiatives funded by the Olympic Refuge Foundation tackle inclusion and hate

04 September 2025 – Four projects have each been awarded USD 50,000 as a part of the Collaborative Action Grant, funded…

1 month ago

/C O R R E C T I O N — Public Interest Registry/

Public Interest Registry Announces 2025 .ORG Impact Awards Finalists, Artist & Actor Common to Host 35 innovative, mission-driven organizations and…

1 month ago

Humbirdy Launches AI Bird Feeder 4K Ultra: Turning Backyards into Personal Nature Documentaries

New York, NY, Sept. 01, 2025 (GLOBE NEWSWIRE) -- For most people, birdwatching begins with a fleeting moment: a small…

2 months ago

Best Ally in the fight against corruption

HONG KONG, Aug. 28, 2025 /PRNewswire/ -- "Hong Kong, our advantage is you and the ICAC". For nearly two decades, the…

2 months ago

Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas

Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…

2 months ago

Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment

Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for…

2 months ago